Verzenio: Information on potential side effects, discount coupons, recommended dosages, and additional details
Verzenio, a medication used to treat breast cancer in certain adults, is currently available as a brand-name drug, but a generic version is expected to hit the market no earlier than September 28, 2031. This timeline may change due to patent challenges, licensing deals, or legal actions affecting patent status.
Prescribed for breast cancer treatment either on its own or in combination with fulvestrant, tamoxifen, or an aromatase inhibitor like anastrozole, Verzenio starts working right after your first dose. The typical dosage is 200 mg twice daily when prescribed alone, and 150 mg twice daily when used with other breast cancer drugs. It's important to note that Verzenio tablets should not be crushed, split, or chewed; they should be swallowed whole.
Verzenio is a kinase inhibitor containing the active drug abemaciclib. While it can be taken with or without food, coffee consumption may cause or worsen diarrhea for some individuals. The medication may also lead to high levels of liver enzymes, which could be a sign of liver damage.
Serious side effects of Verzenio include severe diarrhea, increased creatinine levels, lung conditions such as interstitial lung disease and pneumonitis, blood-related conditions, liver damage, and allergic reactions. Pregnant women or those planning to become pregnant should not take Verzenio, as it may cause harm to the unborn baby. If you're considering pregnancy, discuss this medication with your doctor, who may suggest birth control options during treatment.
Verzenio is not approved for use in children and may increase the risk of both mild and severe infections. It may also cause blood clots and low levels of certain blood cells. Mild side effects include diarrhea, fatigue, nausea and vomiting, decreased appetite, abdominal pain, headache, constipation, stomatitis, fever, dehydration, cough, dizziness, hair loss, and mild infections.
To stay updated on the generic availability of Verzenio, monitor patent status updates on specialized websites like DrugPatentWatch, watch for news about patent litigation outcomes, discuss with your healthcare provider or pharmacist, and check with insurance providers or pharmacy benefit managers for formulary changes related to generics.
Verzenio is approved by the Food and Drug Administration (FDA) to treat breast cancer in adults in certain situations. If you and your doctor determine that Verzenio is safe and effective for you, you may take it long term. However, it's important to note that Verzenio is not available in a generic form yet.
Before taking Verzenio, discuss all your medications, supplements, and certain foods with your doctor and pharmacist to avoid any potential interactions. Your doctor may prescribe a different dosage depending on certain factors, including whether you have severe liver disease.
[1] The cost difference between brand-name and generic drugs is significant because brand-name drugs are protected by patents and involve lengthy and costly development processes. Once patents expire, generics can enter the market, often leading to a reduction in price due to competition.
- In the field of oncology, Verzenio, a medication used to treat breast cancer, is currently available in brand-name form but ageneric version is expected to become available no earlier than September 28, 2031.
- Prescribed to treat breast cancer, Verzenio works effectively on its own or in combination with fulvestrant, tamoxifen, or an aromatase inhibitor like anastrozole, and its dosage varies depending on usage.
- As a kinase inhibitor, Verzenio contains the active drug abemaciclib and can be taken with or without food, although coffee consumption may cause or worsen diarrhea for some individuals.
- Serious medical-conditions associated with Verzenio include severe diarrhea, increased creatinine levels, lung conditions, blood-related conditions, liver damage, and allergic reactions, making it unsuitable for pregnant women.
- While Verzenio may increase the risk of both mild and severe infections in children, it is currently FDA-approved only for adult use in certain situations, and its high cost is due to the patent protection and development costs associated with brand-name drugs.
